[Our experience with the therapeutic use of a new sulfanylurea: N-propyl-N-(p-chlorobenzensulfonyl) urea-P607-by oral route in diabetes mellitus].
D000284:Administration, Oral; D003920:Diabetes Mellitus; D006801:Humans; D007004:Hypoglycemic Agents / Q000628:therapy*; D014508:Urea
D007004:Hypoglycemic Agents; D014508:Urea
ANTIDIABETICS/therapy